[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$faFoFOOp2QlWhkVBx_7X9GwDG8XiH05QueWpsx0Sf9rU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":32,"rows":39},"Frisius Medisch Centrum",[4],47,false,5,3,9086,0,40,[14,16,18,20,22,24,27,29],{"name":15,"count":9},"Septic Shock",{"name":17,"count":9},"Post Intensive Care Unit Syndrome",{"name":19,"count":9},"Critical Illness",{"name":21,"count":9},"Sepsis",{"name":23,"count":9},"Malnutrition",{"name":25,"count":26},"Severe Sepsis",2,{"name":28,"count":26},"Cardiac Arrest",{"name":30,"count":26},"Asthma",[],[33,34,35,36,37,38],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[40,69,93,120,144,169,194],{"intervention":41,"totalTrials":42,"cells":43},"Norepinephrine",1,{"EARLY_PHASE1":44,"PHASE1":46,"PHASE2":48,"PHASE3":50,"PHASE4":52,"NA":67},{"trials":45,"activeCount":11},[],{"trials":47,"activeCount":11},[],{"trials":49,"activeCount":11},[],{"trials":51,"activeCount":11},[],{"trials":53,"activeCount":11},[54],{"nctId":55,"briefTitle":56,"status":57,"phases":58,"primaryCompletion":59,"completion":60,"start":61,"enrollment":62,"conditions":63,"interventions":66},"NCT03806582","Effect of a Higher Blood-pressure on Right Ventricular Function","COMPLETED",[37],"2020-05-15","2020-05-25","2019-03-01",78,[64,65],"Blood Pressure","Right Ventricular Dysfunction",[41],{"trials":68,"activeCount":11},[],{"intervention":70,"totalTrials":42,"cells":71},"ketanserin",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":89,"NA":91},{"trials":73,"activeCount":11},[],{"trials":75,"activeCount":11},[],{"trials":77,"activeCount":11},[],{"trials":79,"activeCount":11},[80],{"nctId":81,"briefTitle":82,"status":57,"phases":83,"primaryCompletion":84,"completion":84,"start":85,"enrollment":86,"conditions":87,"interventions":88},"NCT01329887","The Effect of Ketanserin on the Microcirculation in Sepsis",[36],"2014-05","2011-03",10,[25,15],[70],{"trials":90,"activeCount":11},[],{"trials":92,"activeCount":11},[],{"intervention":94,"totalTrials":42,"cells":95},"Furosemide",{"EARLY_PHASE1":96,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":116,"NA":118},{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[104],{"nctId":105,"briefTitle":106,"status":107,"phases":108,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":115},"NCT00298454","Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients","TERMINATED",[36],"2007-04","2005-12",72,[113,114],"Renal Failure","Critically Ill",[94],{"trials":117,"activeCount":11},[],{"trials":119,"activeCount":11},[],{"intervention":121,"totalTrials":42,"cells":122},"nitroglycerin iv",{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":140,"NA":142},{"trials":124,"activeCount":11},[],{"trials":126,"activeCount":11},[],{"trials":128,"activeCount":11},[],{"trials":130,"activeCount":11},[131],{"nctId":132,"briefTitle":133,"status":57,"phases":134,"primaryCompletion":135,"completion":135,"start":136,"enrollment":137,"conditions":138,"interventions":139},"NCT00493415","The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis",[36],"2008-07","2007-06",70,[21,15],[121],{"trials":141,"activeCount":11},[],{"trials":143,"activeCount":11},[],{"intervention":145,"totalTrials":42,"cells":146},"Magnesium Sulfate",{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":157},{"trials":148,"activeCount":11},[],{"trials":150,"activeCount":11},[],{"trials":152,"activeCount":11},[],{"trials":154,"activeCount":11},[],{"trials":156,"activeCount":11},[],{"trials":158,"activeCount":11},[159],{"nctId":160,"briefTitle":161,"status":57,"phases":162,"primaryCompletion":163,"completion":164,"start":165,"enrollment":166,"conditions":167,"interventions":168},"NCT01332734","Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis",[],"2010-08","2011-01","2010-03",14,[25,15],[145],{"intervention":170,"totalTrials":42,"cells":171},"Hydrochloorthiazide",{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":182},{"trials":173,"activeCount":11},[],{"trials":175,"activeCount":11},[],{"trials":177,"activeCount":11},[],{"trials":179,"activeCount":11},[],{"trials":181,"activeCount":11},[],{"trials":183,"activeCount":11},[184],{"nctId":185,"briefTitle":186,"status":57,"phases":187,"primaryCompletion":188,"completion":188,"start":189,"enrollment":190,"conditions":191,"interventions":193},"NCT01974739","Hydrochloorthiazide and Hypernatriaemie",[38],"2015-05","2013-09",50,[192],"Hypernatraemia",[170],{"intervention":195,"totalTrials":42,"cells":196},"Mepolizumab 100 MG",{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":201,"PHASE3":203,"PHASE4":205,"NA":207},{"trials":198,"activeCount":11},[],{"trials":200,"activeCount":11},[],{"trials":202,"activeCount":11},[],{"trials":204,"activeCount":11},[],{"trials":206,"activeCount":11},[],{"trials":208,"activeCount":11},[209],{"nctId":210,"briefTitle":211,"status":57,"phases":212,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":218},"NCT05441059","Use of Nucala in Severe Asthma",[],"2022-05-01","2021-01-01",2100,[217],"Asthma Severe Persistent Uncontrolled",[195]]